MCIM
AGN

Meadow Creek Investment Management’s Allergan plc AGN Stock Holding History

Meadow Creek Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$2.02M Sell
11,984
-44,604
-79% -$7.27M 0.04% 332
2019
Q2 		$9.47M Sell
56,588
-20,888
-27% -$2.89M 0.19% 105
2019
Q1 		$11.3M Buy
77,476
+29,064
+60% +$4.21M 0.23% 94
2018
Q4 		$6.47M Buy
48,412
+26,880
+125% +$4.41M 0.15% 139
2018
Q3 		$4.1M Sell
21,532
-4,956
-19% -$910K 0.08% 226
2018
Q2 		$4.42M Buy
26,488
+6,748
+34% +$1.08M 0.09% 203
2018
Q1 		$3.32M Buy
19,740
+10,612
+116% +$1.78M 0.07% 234
2017
Q4 		$1.49M Buy
9,128
+1,792
+24% +$322K 0.03% 364
2017
Q3 		$1.5M Buy
7,336
+28
+0.4% +$6.51K 0.04% 331
2017
Q2 		$1.78M Sell
7,308
-47,068
-87% -$11.1M 0.04% 314
2017
Q1 		$13M Sell
54,376
-2,464
-4% -$574K 0.31% 69
2016
Q4 		$11.9M Buy
+56,840
New +$11.8M 0.31% 68

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Meadow Creek Investment Management's AGN Position: Q3 2019 in Review

Meadow Creek Investment Management reduced its Allergan plc (AGN) stake by 79% in Q3 2019, selling an estimated $7.27M and leaving 11,984 shares worth $2.02M. The position accounts for 0.04% of the portfolio, ranked #332.

Meadow Creek Investment Management first reported a position in AGN in Q4 2016 and has held it in 12 quarters since. The position peaked at $13M in Q1 2017. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Meadow Creek Investment Management held 11,984 shares of Allergan plc worth $2.02M as of Q3 2019.
  • Meadow Creek Investment Management sold 44,604 Allergan plc shares in Q3 2019, an estimated $7.27M.
  • Allergan plc made up 0.04% of Meadow Creek Investment Management's portfolio in Q3 2019, its #332 holding.
  • Meadow Creek Investment Management first reported a position in Allergan plc in Q4 2016 and has held it in 12 quarters since.
  • Meadow Creek Investment Management's Allergan plc position peaked at $13M in Q1 2017.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.